Pharmacogenetic Testing in the NHS
Academic Journal Papers
Payne K, Newman W, Fargher EA, Tricker K, Bruce I, Ollier WER. TPMT testing in rheumatology: any better than routine monitoring? Rheumatology 2007; 46(5):727-9.
Fargher EA, Tricker K, Newman B, Elliott RA, Roberts S, Shaffer J, Bruce I, Payne K. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription Journal of Clinical Pharmacy and Therapeutics. 2007; 32(2):187-95.
Clemerson JP, Payne K, Bissell P, Anderson C. Pharmacogenetics – the next challenge for pharmacy? Pharmacy World & Science. 2006; 18(3): 126-131.
Short Papers and Letters
Payne K, Fargher EA, Tricker K, Newman B, Qasim F, Poulton K, Andrews J, Houston JB, Elliott RA, Elles RG, Ray DW, Shaffer J, Griffiths CEM, Bruce IN, Roberts SA, Ollier WER. Research Governance: What is reasonable protection? BMJ Rapid Response. 2005.
Newman B, Payne K, Poulton K, Andrews J, Houston JB, Elliott RA, Elles RG, Ray DW, Shaffer J, Griffiths CEM, Bruce IN, Roberts SA, Qasim F, Ollier WER. The TARGET (TPMT: Azathioprine Response to Genotyping and Enzyme Testing) study. BMJ Rapid Response. 2005.
Spoken Conference Presentations
Clemerson J, Payne K, Bissell P, Anderson C. Pharmacogenetics: Pharmacists understanding and opinions of an emerging field of healthcare. 14th International Social Pharmacy Workshop, Oxford, July 2006.
Jess Clemerson’s presentation was awarded ‘highly commended’. International Journal of Pharmacy Practice. 2006; 14 supplement 1: A6.
Clemerson J, Bissell P, Anderson C, Payne K. Pharmacogenetics: The next challenge for pharmacy? Health Services Research & Pharmacy Practice Conference, May 2006.
Payne K, Newman B, Fargher EA, Tricker K, Parameshwar S, Alder J, Poulton K, Andrews J, Houston, JB, Elliott RA, Elles RG, Ray DW, Shaffer J, Griffiths CE, Bruce IN, Roberts SA, Qasim F, Ollier WER. Implementing a prospective trial of a pharmacogenetic test: early lessons learned. Cold Spring Harbor Laboratory/Wellcome Trust – Pharmacogenomics Meeting. Cambridge, September 2005.
Payne K, Fargher EA, Tricker K, Elliott RA. Prospective evaluation of a pharmacogenetic test: application of an economic framework. Cold Spring Harbor Laboratory/Wellcome Trust – Pharmacogenomics Meeting. Cambridge, September 2005.
Posters
Fargher EA, Payne K, Tricker KJ, Newman W, Bruce IN. Pre-treatment TPMT testing in rheumatology. British Society of Rheumatology & BHPR Spring Meeting, May 2007.
Fargher EA, Payne K, Eddy C, Tricker K, Elliott RA, Qasim F, Bruce I, Griffiths C, Moriarty K, Pearson, C, Newman B. Who will be responsible for pharmacogenetics in the NHS? Annual Meeting for the British Society of Human Genetics. York, September 2006.
Journal of Medical Genetics; 2006: 43 (Supplement 1): s109.
Fargher EA, Payne K, Tricker K, Newman W, Elliott RA, Shaffer J, Griffiths C, Bruce I. Pharmacogenetic testing for azathioprine in the NHS: Current uptake and implications for prescribing practice. British Pharmaceutical Conference. Manchester, September 2006.
Awarded best practice research poster prize. International Journal of Pharmacy Practice. 2006; 14 (Supplement 2): b70-71.
Eddy C, Fargher EA, Newman B, Pearson C, Moriarty K, Payne K. Exploring patients’ views on pharmacogenetic testing. European Human Genetics Conference in conjunction with the European Meeting on Psychosocial Aspects of Genetics, Amsterdam, 2006.
European Journal of Human Genetics. 2006; 14, (Supplement 1): 409.
Alder JE , Sidgwick GP, Newman W, Parameshwar S, Tricker K, Payne K, Fargher EA, Poulton K, Qasim F, Houston JB, Elliott RA, Elles RG, Ray DW, Shaffer J, Griffiths CE, Bruce IN, Roberts SA, Andrews J and Ollier WE. Preliminary Phenotyping Studies in the TARGET Project: Thiopurine
Methyltransferase Measurements and Azathioprine Metabolite Profiling. Personalised Medicines Symposium. Warwick, July 2006.
Fargher EA, Eddy CE, Payne K, Tricker K, Elliott RA, Ollier WE, Qasim F, Bruce I, Shaffer J, Griffiths C, Moriarty K, Pearson C, Newman W. Exploring patients’ and healthcare professionals’ views of pharmacogenetic testing. Personalised Medicines Symposium. Warwick, July 2006.
Payne K, Pushpakom SP, Fargher EA, Tricker K, Alder J, Poulton K, Andrews J, Houston JB, Elliott, RA, Elles RG, Ray DW, Shaffer J, Griffiths CE, Bruce IN, Roberts SA, Qasim F, Newman B, Ollier. WER. The TARGET (TPMT: AZA RESPONSE TO GENOTYPING AND ENZYME TESTING) Study. Cold Spring Harbor Laboratory/Wellcome Trust- Pharmacogenomics Meeting. Cambridge, September 2005.
